Carcinogenicity and mechanism of action of fumonisin B1:: a mycotoxin produced by Fusarium moniliforme (= F-verticillioides)

被引:72
作者
Voss, KA
Howard, PC
Riley, RT
Sharma, RP
Bucci, TJ
Lorentzen, RJ
机构
[1] USDA ARS, Richard B Russell Agr Res Ctr, Toxicol & Mycotoxin Res Unit, Athens, GA 30604 USA
[2] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[3] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA
[4] Expt Pathol Associates, Jefferson, AR 72079 USA
[5] US FDA, Ctr Food Safety & Nutr, Washington, DC 20204 USA
来源
CANCER DETECTION AND PREVENTION | 2002年 / 26卷 / 01期
关键词
fumonisin B-1; Fusarium moniliforme (= F verticillioides); carcinogenicity; sphingolipids; tumor necrosis factor alpha;
D O I
10.1016/S0361-090X(02)00011-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fumonisins are fungal metabolites and suspected human carcinogens. They inhibit ceramide synthase in vitro, enhance tumor necrosis factor alpha (TNFalpha) production, and cause apoptosis. Fumonisin B-1 (FB1) was fed to rats and mice for 2 years or, in separate studies, given to rats or mice for up to 4 weeks. Kidney tubule adenomas and carcinomas were found in male rats fed greater than or equal to50 ppm, whereas liver adenomas and carcinomas were found in female mice fed greater than or equal to50 ppm for 2 years. In the short-term studies, increases in tissue concentration of the ceramide synthase substrate sphinganine (Sa) and the Sa to sphingosine (So) ratio were correlated with apoptosis. Further, hepatotoxicity was ameliorated in mice lacking either the TNFR1 or the TNFR2 TN-Falpha receptors. Thus, FB1 was carcinogenic to rodents and the findings support the hypothesis that disrupted sphingolipid metabolism and TNFalpha play important roles in its mode of action. (C) 2002 International Society for Preventive Oncology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 49 条
[41]   Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks [J].
Turner, PC ;
Nikiema, P ;
Wild, CP .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1999, 443 (1-2) :81-93
[42]   An overview of rodent toxicities:: Liver and kidney effects of fumonisins and Fusarium moniliforme [J].
Voss, KA ;
Riley, RT ;
Norred, WP ;
Bacon, CW ;
Meredith, FI ;
Howard, PC ;
Plattner, RD ;
Collins, TFX ;
Hansen, DK ;
Porter, JK .
ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 :259-266
[43]   SUBCHRONIC FEEDING STUDY OF THE MYCOTOXIN FUMONISIN B1 IN B6C3F1 MICE AND FISCHER-344 RATS [J].
VOSS, KA ;
CHAMBERLAIN, WJ ;
BACON, CW ;
HERBERT, RA ;
WALTERS, DB ;
NORRED, WP .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1995, 24 (01) :102-110
[44]  
Voss Kenneth A., 1993, Natural Toxins, V1, P222, DOI 10.1002/nt.2620010404
[45]  
WANG E, 1991, J BIOL CHEM, V266, P14486
[46]  
*WHO, 2000, FUM B1 INT PROGR CHE
[47]  
YANG CS, 1980, CANCER RES, V40, P2633
[48]   Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity [J].
Yoo, HS ;
Norred, WP ;
Showker, J ;
Riley, RT .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 138 (02) :211-218
[49]   FUMONISIN OCCURRENCE IN CORN FROM HIGH-RISK AND LOW-RISK AREAS FOR HUMAN ESOPHAGEAL CANCER IN CHINA [J].
YOSHIZAWA, T ;
YAMASHITA, A ;
LUO, Y .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1994, 60 (05) :1626-1629